GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Interest Expense

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Interest Expense : ¥-20 Mil (TTM As of Mar. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Hainan Huluwa Pharmaceutical Group Co Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Hainan Huluwa Pharmaceutical Group Co's interest expense for the three months ended in Mar. 2024 was ¥ -6 Mil. Its interest expense for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-20 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Hainan Huluwa Pharmaceutical Group Co's Operating Income for the three months ended in Mar. 2024 was ¥ 40 Mil. Hainan Huluwa Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2024 was ¥ -6 Mil. Hainan Huluwa Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2024 was 6.74. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hainan Huluwa Pharmaceutical Group Co Interest Expense Historical Data

The historical data trend for Hainan Huluwa Pharmaceutical Group Co's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Hainan Huluwa Pharmaceutical Group Co Interest Expense Chart

Hainan Huluwa Pharmaceutical Group Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Interest Expense
Get a 7-Day Free Trial -13.36 -9.10 -13.87 -18.00 -18.24

Hainan Huluwa Pharmaceutical Group Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Interest Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.81 -4.29 -7.33 -2.80 -5.88

Hainan Huluwa Pharmaceutical Group Co Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-20 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Hainan Huluwa Pharmaceutical Group Co  (SHSE:605199) Interest Expense Explanation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense. The higher, the better.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Hainan Huluwa Pharmaceutical Group Co's Interest Expense for the three months ended in Mar. 2024 was ¥-6 Mil. Its Operating Income for the three months ended in Mar. 2024 was ¥40 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Mar. 2024 was ¥545 Mil.

Hainan Huluwa Pharmaceutical Group Co's Interest Coverage for the quarter that ended in Mar. 2024 is calculated as

Interest Coverage=-1* Operating Income (Q: Mar. 2024 )/Interest Expense (Q: Mar. 2024 )
=-1*39.678/-5.884
=6.74

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's financial strength is.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Hainan Huluwa Pharmaceutical Group Co Ltd (SHSE:605199) » Definitions » Interest Expense
Comparable Companies
SHSE:600789 SZSE:000566 SHSE:688553 SZSE:002437 SHSE:603367 SZSE:002793 SZSE:301089 SZSE:002728 SHSE:688073 SZSE:300683 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No. 8, Yaogu 4th Road, Phase II, Yaogu Industrial Park, Haikou National High-tech Zone, Hainan Province, Haikou, CHN, 570300
Website
http://www.huluwayaoye.com
Hainan Huluwa Pharmaceutical Group Co Ltd is engaged in production and sales of Chinese patent medicines and chemical drugs. The company produces medicines for children's respiratory and digestive systems. Its products include star products, calabash, gourd dad, and gourd mom.

Hainan Huluwa Pharmaceutical Group Co (SHSE:605199) Headlines

No Headlines